ArticleClinical kidney journal2024

Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials.

Roberto Minutolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.